Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
32.89
+0.87 (2.72%)
At close: Aug 7, 2026, 4:00 PM EDT
32.99
+0.10 (0.30%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.36 billion as of August 7, 2026. Its market cap has increased by 92.16% in one year.
Market Cap
2.36B
Enterprise Value
1.84B
1-Year Change
92.16%
Ranking
Category
Stock Price
$32.89
ChartMarket Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.36B, an increase of 948.04%. That is a compound annual growth rate of 56.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 2.36B | -34.32% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.44B |
| Kailera Therapeutics | 2.42B |
| Mineralys Therapeutics | 2.41B |
| SELLAS Life Sciences Group | 2.36B |
| Hemab Therapeutics Holdings | 2.32B |
| Nuvation Bio | 2.32B |
| Vericel | 2.31B |
| Sionna Therapeutics | 2.30B |